Medical Condition News

RSS

New defibrillator offers advantages for young patients with congenital heart problems

A new ground-breaking technology was recently used at the University of Ottawa Heart Institute (UOHI) where two cardiologists, Dr. David Birnie and Dr. Pablo Nery, implanted a new innovative leadless defibrillator, the subcutaneous implantable cardioverter defibrillator (S-ICD), to a 18 year-old patient. Under Health Canada's special access program, this was only the third time this new type of ICD had been implanted in Canada.

4 Oct 2012

Scripps Health receives Qualcomm Foundation grant to support digital medicine research projects

Scripps Health announced today that it has been awarded a $3.75 million grant from the Qualcomm Foundation, to be used for the Scripps Translational Science Institute, which was established by Scripps Health in collaboration with various parties to support the development of breakthrough digital technologies designed to revolutionize the practice of medicine.

4 Oct 2012

Krembil scientists develop lab study to accurately predict outcomes of stroke neuroprotectant

Scientists at the Krembil Neuroscience Centre, located at the Toronto Western Hospital, University Health Network have developed the first lab study in the world to accurately predict the outcomes of a human clinical for their drug that protects the brain against the damaging effects of stroke.

4 Oct 2012

Ketamine can help improve brain function in Rett syndrome mice

A promising study out today in the prestigious Journal of Neurosciences showed that in a mouse model of Rett syndrome, researchers were able to reverse abnormalities in brain activity and improve neurological function by treating the animals with an FDA-approved anesthesia drug, ketamine.

4 Oct 2012

Heavy caffeinated coffee consumption may increase risk of exfoliation glaucoma

A new study suggests caffeinated coffee drinkers should limit their intake to reduce their chances of developing vision loss or blindness. According to a scientific paper in Investigative Ophthalmology & Visual Science, heavy caffeinated coffee consumption is associated with an increased risk of developing exfoliation glaucoma, the leading cause of secondary glaucoma worldwide.

4 Oct 2012

Long-term survivors of hematopoietic cell transplants more likely to develop heart disease

New research appearing online today in Blood, the Journal of the American Society of Hematology (ASH), suggests that long-term survivors of hematopoietic cell transplants (HCT) are at an increased risk of developing heart disease risk factors such as high blood pressure, diabetes, and high cholesterol when compared to the general population.

4 Oct 2012

Beta-blockers not associated with reduced risk of heart attacks, death and strokes

A new study conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found using beta-blockers, the standard of care for patients with coronary artery disease (CAD), was not associated with a lower risk of heart attacks, death and strokes in patients suffering from CAD and those with risk factors for the disease, including those with a history of heart attack.

4 Oct 2012

Esthesiometry may help vision professionals in evaluating dry eyes

A simple test of eyelid sensitivity may help vision professionals in evaluating one of the most common eye-related symptoms: dry eyes. A new study linking increased eyelid sensitivity to decreased function of the eyelid margins is presented in the article - " Lid Margins: Sensitivity, Staining, Meibomian Gland Dysfunction, and Symptoms", appearing in the October issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

4 Oct 2012

Premier, ArjoHuntleigh announce three-year contract for vascular compression therapy systems

ArjoHuntleigh announced today that it has been awarded a three-year contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, for its vascular compression therapy systems.

4 Oct 2012

SLU professor to investigate natural history and progression of Alpha-1 Antitrypsin Deficiency

Jeffrey Teckman, M.D., professor of pediatrics and biochemistry and molecular biology at Saint Louis University, has received a $1.4 million grant from the Alpha-1 Foundation to investigate the natural history and progression of Alpha-1 Antitrypsin Deficiency, an inherited disease that can cause liver damage in children as well as adults.

4 Oct 2012

Nursing intervention can significantly decrease substance abuse among homeless youth

A new study led by researchers from the UCLA School of Nursing has found that nursing intervention can significantly decrease substance abuse among homeless youth.

4 Oct 2012

Study to determine link between foot injuries and ill-fitting shoes

Loyola University Medical Center researchers are conducting a first-of-its kind study of marathon runners to determine if there is link between foot injuries and ill-fitting shoes.

4 Oct 2012

Biceps tenodesis hastens recovery, cuts rehabilitation time for labrum tears

Athletics have always been a part of Jade Dismore's life. The 27-year-old native of South Africa grew up playing tennis and swimming; as an adult she became an avid runner and recreational volleyball player. For several years she felt soreness in her shoulder, but assumed it was nothing serious. As she began training for her first triathlon, the pain became increasingly severe. After trying to manage the pain on her own for years, Dismore decided it was time to seek medical attention.

4 Oct 2012

Court approves Abbott settlement for wrongly marketing Depakote

The pharmaceutical company will pay $1.5 billion for marketing the drug for non-approved uses.

4 Oct 2012

Mayo Clinic releases new app to help fight anxiety

Mayo Clinic is releasing an app this week for Apple iPhones, iPads and iPod Touch called Anxiety Coach, a self-help tool that assists people in reducing a variety of fears and worries ranging from extreme shyness to obsessions and compulsions.

4 Oct 2012

New type of drug for drug-resistant cancer

New drug may be an effective alternative for patients whose cancer is resistant to currently available drugs.

4 Oct 2012

Circassia commences ToleroMune phase 3 trial in cat allergen-induced rhinoconjunctivitis

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the start of a pivotal phase 3 trial of its investigational ToleroMune cat allergy treatment for cat allergen-induced rhinoconjunctivitis.

4 Oct 2012

Simple new test can monitor treatment of eosinophilic esophagitis

A simple new test, in which the patient swallows a string, can monitor treatment of eosinophilic esophagitis as effectively as an invasive, expensive and uncomfortable procedure that risks complications, particularly in children.

4 Oct 2012

Novel technology can identify potential biomarkers of ulcerative colitis

Scientists from the Florida campus of The Scripps Research Institute have developed a novel technology that can identify, in animal models, potential biomarkers of ulcerative colitis, a type of inflammatory bowel disease that affects the lining of the colon.

4 Oct 2012

Stereocilia not only move sideways but also change in length: Study

The sensory cells of the inner ear have tiny hairs called stereocilia that play a critical part in hearing. It has long been known that these stereocilia move sideways back and forth in a wave-like motion when stimulated by a sound wave. After having designed a microscope to observe these movements, a research team at Karolinska Institutet in Sweden has discovered that the hairs not only move sideways but also change in length.

4 Oct 2012

Medical Condition News

New defibrillator offers advantages for young patients with congenital heart problems

Scripps Health receives Qualcomm Foundation grant to support digital medicine research projects

Krembil scientists develop lab study to accurately predict outcomes of stroke neuroprotectant

Ketamine can help improve brain function in Rett syndrome mice

Heavy caffeinated coffee consumption may increase risk of exfoliation glaucoma

Long-term survivors of hematopoietic cell transplants more likely to develop heart disease

Beta-blockers not associated with reduced risk of heart attacks, death and strokes

Esthesiometry may help vision professionals in evaluating dry eyes

Premier, ArjoHuntleigh announce three-year contract for vascular compression therapy systems

SLU professor to investigate natural history and progression of Alpha-1 Antitrypsin Deficiency

Nursing intervention can significantly decrease substance abuse among homeless youth

Study to determine link between foot injuries and ill-fitting shoes

Biceps tenodesis hastens recovery, cuts rehabilitation time for labrum tears

Court approves Abbott settlement for wrongly marketing Depakote

Mayo Clinic releases new app to help fight anxiety

New type of drug for drug-resistant cancer

Circassia commences ToleroMune phase 3 trial in cat allergen-induced rhinoconjunctivitis

Simple new test can monitor treatment of eosinophilic esophagitis

Novel technology can identify potential biomarkers of ulcerative colitis

Stereocilia not only move sideways but also change in length: Study

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News